Molecular Medicine Partnership Unit Medical Campus of the University of Heidelberg, Germany. Research themes place emphasis on common diseases, particularly blood disorders, cancer, iron metabolism disorders, chronic pain, diseases associated with aging, and AIDS. In 2018 more than 110 scientists from across the world work on these eight research themes: Molecular Medicine Partnership Unit The Molecular Medicine Partnership Unit (MMPU) is an alliance between the European Molecular Biology Laboratory (EMBL) and the Medical Faculty of the University of Heidelberg. Its primary aim is to uncover the molecular basis of disease and to speed the transformation of biomedical discoveries into personalized medicine strategies. Founded in
Intensive care medicine Intensive care medicine Intensive care medicine, or critical care medicine, is a branch of medicine concerned with the diagnosis and management of life-threatening conditions that may require sophisticated life support and monitoring. Patients requiring intensive care may require support for instability (hypertension/hypotension), airway or respiratory compromise (such as ventilator support), acute renal failure, potentially lethal cardiac arrhythmias, or the cumulative effects of multiple organ failure, more commonly referred to now as multiple organ dysfunction syndrome. They may also be admitted for intensive/invasive monitoring, such as the crucial hours after major surgery when deemed too unstable to transfer to a less